本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corcept醫療

112.79
-2.1300-1.85%
盤後112.790.00000.00%19:59 EDT
成交量:128.25萬
成交額:1.44億
市值:121.92億
市盈率:248.63
高:117.84
開:115.22
低:109.30
收:114.92
52周最高:126.38
52周最低:28.66
股本:1.08億
流通股本:9,644.01萬
量比:1.82
換手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):0.4537
每股收益(LYR):0.8200
淨資產收益率:8.23%
總資產收益率:0.47%
市淨率:17.28
市盈率(LYR):137.55

資料載入中...

2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans